A few developments in the marijuana industry have kept shorts of cannabis stocks at bay, a new report from research firm S3 Analytics stated.

On Wednesday (November 20), the firm published a study indicating short sellers of the marijuana public market were down US$272 million during the trading session, for the top 20 cannabis stocks tracked by S3 Analytics.

The report noted that short exposure for cannabis is up 16 percent so far this year for a total of US$389 million.

“Short selling is fairly concentrated to a handful of names, with only six stocks topping US$100 million of short interest,” the report said. It was authored by Ihor Dusaniwsky, managing director of predictive analytics at S3 Partners — the parent firm of S3 Analytics.

The researcher identified that the short market has seen a year-long trend of net short selling for the top 20 cannabis names and has so far reached US$1.41 billion.

“The increased short selling was needed to maintain overall short exposure in the sector as sector-wide price weakness decreased the notional value of the total short positions by just over US$1 billion,” Dusaniwsky wrote.

According to the report, a combination of the positive vote for the Marijuana Opportunity Reinvestment and Expungement Act (MORE Act) by the House Judiciary Committee helped cause the drop for shorts.

Alongside the vote, the following developments also caused the short dip:

  • Canopy Growth (NYSE:CGC,TSX:WEED) obtaining a rate raise from the wealth management division of Bank of America (NYSE:BAC);
  • Cronos Group (NASDAQ:CRON,TSX:CRON) investee Altria Group (NYSE:MO) upping its stake in the marijuana company to keep a 45 percent ownership of Cronos; and
  • The Green Organic Dutchman (TSX:TGOD,OTCQX:TGODF) announcing distribution for its products in Alberta, Manitoba and Nova Scotia.

Dusaniwsky said the top shorted stocks from the leading pack of 20 were Cronos, Canopy Growth and GW Pharma (NYSE:GWPH).

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less